Central Sleep Apnea (CSA) Treatment with Remedē by Respicardia

Comprehensive Sleep Care Center located in Virginia and Maryland (Alexandria, Arlington, Bethesda, Chantilly, Dumfries, Germantown, Lansdowne, Manassas, Woodbridge) is proud to announce the Remedē by Respicardia treatment for Central Sleep Apnea.

The remedē system by Respicardia is an innovative implantable system for treating moderate to severe Central Sleep Apnea (CSA) in adults.

The remedē System is FDA approved and clinically proven to reduce Central Sleep Apnea events and improve the quality of sleep. Remedē provides much needed relief for Central Sleep Apnea patients who struggle with ASV, CPAP or BiPAP and suffer from daytime sleepiness.

Our sleep doctors will evaluate your overall health and current Central Sleep Apnea treatment to determine if remedē might be a suitable alternative for you.

Respicardia Device

Remedē Can Help Treat Your Central Sleep Apnea

Comprehensive Sleep Care Center proudly offers the remedē® System. Remedē is a safe and effective alternative treatment for adults with moderate to severe Central Sleep Apnea (CSA), and those who are unable to tolerate ASV, CPAP or BiPAP therapy.

The device works automatically throughout the night to monitor and stabilize a patient’s breathing pattern and reduce the effects of Central Sleep Apnea (CSA).

Improve Your CSA and Improve Your Quality of Life

Central Sleep Apnea is associated with many symptoms that may impact your health and quality of life.

  • Shortness of breath at night
  • Daytime fatigue
  • Breathing temporarily stops
  • Low stamina
  • Trouble concentrating
  • Frequent night time urination

Many patients who suffer from Central Sleep Apnea also have heart disease. Patients may also be at increased risk for hospitalization and even heart failure.

Central Sleep Apnea Can Also be Associated With

  • Cardiac disorders including Congestive Heart Failure and Atrial Fibrillation
  • High altitudes
  • Opioid use
  • Idiopathic Central Sleep Apnea
  • Other medical conditions such as stroke or brainstem/spinal cord disorders

How Remedē / Respicardia Works to Treat CSA

The remedē System is an implantable system which stimulates the phrenic nerve in the chest. It sends signals to the large muscle between the chest and abdomen to stimulate breathing in the patient in the same way that the brain does.

A small device is implanted by a trained cardiologist under the skin in the upper part of the chest and thin lead wires are inserted into the blood vessels near the phrenic nerve.

The patient’s respiratory signals are monitored while sleeping and the nerve is stimulated to move the diaphragm to restore normal breathing patterns.

What to Expect with Remedē

Our sleep doctors will evaluate your overall health and current Central Sleep Apnea treatments to determine if remedē might be a suitable alternative for you. You may need to have a current in-lab sleep study done to get a baseline for treatment.

The procedure is minimally invasive and is usually an outpatient procedure performed with light sedation.

A small device will be place under your skin in the upper area of your chest. This device will continuously monitor your breathing and stabilize it while you sleep.

Most patients can resume much of their normal routine within a week or so. However, you will be asked not to lift your arm above shoulder height for a period of time after the procedure.

We see many patients who have stopped using or are unable to tolerate ASV or PAP Therapy.  Remedē therapy represents a significant advance in Central Sleep Apnea treatment and is clinically proven to reduce central apnea events. We have seen a high level of patient satisfaction and therapy adherence with remedē, and we’re excited to be able to offer this promising therapy to patients.

Learn more about Remedē